| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |